Stock DNA
Pharmaceuticals & Biotechnology
CNY 1,350 Million (Small Cap)
22.00
NA
0.00%
-0.65
7.47%
0.83
Revenue and Profits:
Net Sales:
223 Million
(Quarterly Results - Sep 2025)
Net Profit:
27 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.83%
0%
-7.83%
6 Months
-12.1%
0%
-12.1%
1 Year
3.21%
0%
3.21%
2 Years
11.1%
0%
11.1%
3 Years
-4.48%
0%
-4.48%
4 Years
-20.06%
0%
-20.06%
5 Years
0%
0%
0.0%
Weihai Baihe Biology Technological Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.35%
EBIT Growth (5y)
-9.37%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.68
Sales to Capital Employed (avg)
0.53
Tax Ratio
13.53%
Dividend Payout Ratio
33.86%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
35.53%
ROE (avg)
10.04%
Valuation key factors
Factor
Value
P/E Ratio
22
Industry P/E
Price to Book Value
1.70
EV to EBIT
14.54
EV to EBITDA
11.43
EV to Capital Employed
3.13
EV to Sales
2.14
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
21.49%
ROE (Latest)
7.66%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
223.50
192.80
15.92%
Operating Profit (PBDIT) excl Other Income
23.60
30.30
-22.11%
Interest
0.10
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
27.10
33.70
-19.58%
Operating Profit Margin (Excl OI)
105.60%
157.10%
-5.15%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is 15.92% vs 5.36% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is -19.58% vs 8.01% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
794.60
864.60
-8.10%
Operating Profit (PBDIT) excl Other Income
174.40
204.70
-14.80%
Interest
0.20
0.20
Exceptional Items
0.00
0.00
Consolidate Net Profit
139.30
169.10
-17.62%
Operating Profit Margin (Excl OI)
167.70%
193.60%
-2.59%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -8.10% vs 20.05% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -17.62% vs 22.71% in Dec 2023
About Weihai Baihe Biology Technological Co., Ltd. 
Weihai Baihe Biology Technological Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






